Skip to main content
. Author manuscript; available in PMC: 2018 Oct 15.
Published in final edited form as: Int J Cancer. 2018 Aug 9;143(8):1963–1977. doi: 10.1002/ijc.31586

Figure 2. sCEA activates fibroblasts through the AKT-mTOR C1/STAT3 signalling pathways.

Figure 2.

A. Addition of sCEA to HNNFb cultures activates a signalling through the AKT-mTOR C1 as well as the STAT3 signalling axes. B. Pharmacological reversal of α-SMA expression in sCEA-activated HNNFbs upon the addition of AKT-mTOR C1 inhibitors palomid-529 or pentoxifylline.